Faron, etusivu

releases and publications

Faron to Participate at Canaccord Conference

Grant of options

Insider Transaction Regulatory

Faron to Hold BEXMAB Study Conference Call

BEXMAB study Update

Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Announcement of Placing

Regulatory

Exercise of options

Regulatory

New biomarker data from BEXMAB study at EHA2023

Board Member to Assume Transactional Advisor Role

Regulatory

Bexmarilimab Efficacy and Safety in MATINS Trial

PreviousNext
Back to top